Introduction:Ramadan is the ninth lunar month of the Muslim calendar, and fasting
during Ramadan is one of the five pillars of Islam. Muslim cancer patients and
health professionals are faced with a dilemma between the necessity of fasting
and its possible adverse effects during Ramadan on the health status of cancer
patients. We believe that addressing the issue of fasting in cancer patients is
of global interest. Objectives: Prevalence of fasting in cancer patients
during Ramadan; Predictive factors of Ramadan fasting in cancer patients; The effect of
fasting during Ramadan on the quality of life of cancer patients. Materials and Methods: A structured
questionnaire was used to interview adult cancer patients who received
chemotherapy IV—or oral treatment at the medical oncology department at
the Hassan II University Hospital in Fez during the month of Ramadan 1443 Hijri
(April to May 2022). The quality of cancer patients’ lives during their fasting
practice in Ramadan was evaluated via the QLQ-C30 questionnaires. Results: 48% of patients did not fast during Ramadan, 22% and 30% were partial and
complete fasters respectively. Patients, with OMS 0 to 1, who receive
outpatient treatment, non-metastatic patients and patients on oral treatment
were more frequent in the completely fasted group. All these factors showed
statistically significant values (p < 0.05). 44% of patients sought advice
from the treating oncologist if they could fast, while only 15% of patients
during Ramadan asked an imam if they could be excused from fasting. A
comparison of the QLQ-C30 data showed a significant improvement in emotional
functioning with fasting, however,
References
[1]
Nencioni, A., Caffa, I., Cortellino, S. and Longo, V.D. (2018) Fasting and Cancer: Molecular Mechanisms and Clinical Application. Nature Reviews Cancer, 18, 707-719.
https://doi.org/10.1038/s41568-018-0061-0
[2]
Patterson, R.E. and Sears, D.D. (2017) Effects Intermittent Fasting Metabolics. Annual Review of Nutrition, 37, 371-393.
https://doi.org/10.1146/annurev-nutr-071816-064634
[3]
Lee, C., Safdie, F.M., Raffaghello, L., Wei, M., Madia, F., Parrella, E., et al. (2010) Reduced Levels of IGF1 Provide Differential Protection of Normal and Cancerous Cells in Response to Fasting and Are Responsible for the Chemotherapeutic Index. Cancer Research, 70, 1564-1572. https://doi.org/10.1158/0008-5472.CAN-09-3228
[4]
Aaronson, N.K., Ahmedzai, S., Bergman. B., Bullinger, M., Cull, A., Duez, N.J., et al. (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology. Journal of the National Cancer Institute, 85, 365-376.
https://doi.org/10.1093/jnci/85.5.365
[5]
(2011) Islam Is the Second Largest Religion in the World.
http://www.islamicweb.com/begin/results.htm
[6]
Zeeneldin, A.A. and Taha, F.M. (2012) Fasting among Muslim Cancer Patients during the Holy Month of Ramadan.
[7]
Tas, F., Karabulut, S., Ciftci, R., Yildiz, I., et al. (2014) The Behavior of Turkish Cancer Patients in Fasting during the Holy Month of Ramadan. Japanese Journal of Clinical Oncology, 44, 705-710. https://doi.org/10.1093/jjco/hyu070
[8]
AL Wakeel, J., Mitwali, A.H., Alsuwaida, A., Al Ghonaim, M., Usama, S., Hayat, A., et al. (2013) Recommendations for Fasting in Ramadan for Patients on Peritoneal Dialysis. Peritoneal Dialysis International, 33, 86-91.
https://doi.org/0.3747/pdi.2010.00095
[9]
Alshammari, K., Alhaidal , H.A., Alharbi, R., Alrubaiaan, A., Abdel-Razaq, W., Alyousif, G. and Alkaiyat, M. (2023) The Impact of Fasting the Holy Month of Ramadan on Colorectal Cancer Patients and Two Tumor Biomarkers: A Tertiary-Care Hospital Experience. Cureus, 15, e33920. https://doi.org/10.7759/cureus.33920
[10]
Bauersfeld, S., Kessler, C.S., Jaensch, A., Steckhan, N., Stange, R., et al. (2018) The Effects of Short-Term Fasting on Quality of Life and Tolerance to Chemotherapy in Patients with Breast and Ovarian Cancer: A Randomized Cross-Over Pilot Study. BMC Cancer, 18, Article No. 476. https://doi.org/10.1186/s12885-018-4353-2